Title 21 Job Opportunities
The 21st Century Cures Act was enacted on December 13, 2016 and Section 3072 of the Act grants the Commissioner of Food and Drugs the authority to appoint and set the annual rate of pay for outstanding and qualified candidates to scientific, technical, or professional positions that support the development, review, and regulation of medical products. The FY23 Food and Drug Omnibus Reform Act expanded this authority further amending Title 21 to include cross-cutting operational positions and individuals that support the development review and regulation of food and cosmetics in addition medical products. (codified into Title 21 of the United States Code (21 US Code 379d-3a).
The positions listed below are being filled under Title 21. The candidate selected for these positions will serve under a career or career-conditional appointment and be paid under the provisions of the authority. Additional information on 21st Century Cures Act can be found here
Title 21 Open Vacancies
Associate Director for Rare Disease Strategy
Center for Drug Evaluation and Research (CDER)
Closing date: August 16, 2024
Associate Director for Therapeutic Review (Supervisory Physician)
Center for Drug Evaluation and Research (CDER)
Closing date: August 12, 2024
Physician
Center for Drug Evaluation and Research (CDER)
Closing date: July 31, 2024
Pharmacist
Center for Drug Evaluation and Research (CDER)
Closing date: July 30, 2024
Physician
Center for Drug Evaluation and Research (CDER)
Closing date: August 2, 2024
Lead General Health Scientist
Center for Drug Evaluation and Research (CDER)
Closing date: August 15, 2024
Data Scientist (Cures Band C)
Center for Devices and Radiological Health (CDRH)
Closing Date: August 10, 2024
Data Scientist (Cures Band D)
Center for Devices and Radiological Health (CDRH)
Closing Date: August 10, 2024
Social Scientist/ Psychometrician
Center for Devices and Radiological Health (CDRH)
Closing Date: August 10, 2024
Senior Regulatory Health Project Manager
Center for Drug Evaluation and Research (CDER)
Closing date: July 30, 2024
OM Deputy Office Director
Center for Biologics Evaluation and Research (CBER)
Closing date: July 29, 2024
Data Scientist
Center for Biologics Evaluation and Research (CBER)
Closing date: July 25, 2024
Project Manager
Center for Biologics Evaluation and Research (CBER)
Closing date: July 22, 2024
Information Technologist
Center for Biologics Evaluation and Research (CBER)
Closing date: July 22, 2024
Office Director, OTED
Office of Regulatory Affairs (ORA)
Closing date: July 16, 2024
Policy & Operations Branch Chief, Division of User Fee Management
Center for Drug Evaluation and Research (CDER)
Closing date: July 15, 2024
Regulatory Policy Analyst (Band C)
Center for Drug Evaluation and Research (CDER)
Closing date: July 31, 2024
Regulatory Policy Analyst (Band D)
Center for Drug Evaluation and Research (CDER)
Closing date: July 31, 2024
Regulatory Counsel (Band C)
Center for Drug Evaluation and Research (CDER)
Closing date: July 22, 2024
Regulatory Counsel (Band D)
Center for Drug Evaluation and Research (CDER)
Closing date: July 22, 2024
Pharmacologist/Toxicologist
Center for Drug Evaluation and Research (CDER)
Closing Date: July 22, 2024
Biologist
Center for Drug Evaluation and Research (CDER)
Closing Date: July 22, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing Date: July 22, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Physician
Center for Biologics Evaluation and Research (CBER)
Closing date: Open continuously; applications will be reviewed periodically
Investigator II/Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 22, 2024
Physician, Office of Therapeutic Products (OTP)
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically